Subtype
Pleural Malignant Mesothelioma
CI-CAN-00001425Explore in graph →
Loading cancer entity…
Subtype
CI-CAN-00001425Explore in graph →
Variants & evidence
11 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|
| BAP1 Loss1 | |||||||
| EPZ011989 | Predictive | D | Supports Sensitivity Response | 2 | submitted | EID8329The in vivo experiment demonstrated that Bap1 loss results in increased trimethylated histone H3 lysine 27 (H3K27me3), elevated Ezh2 expression, and enhanced repression of Polycomb Repressive Complex … (full text at CIViC) PMID 26437366 · LaFave et al., 2015 · Open in CIViC | civic |
| BAP1 Mutation1 | |||||||
| CDK4/6 Inhibition | Predictive | D | Supports Sensitivity Response | 4 | submitted | EID12008The effect of CDK4/6 inhibitors (abemaciclib or palbociclib) was tested in patient-derived malignant pleural mesothelioma (MLM) cell lines. Of the three patient-derived cell lines, two of the cell lin… (full text at CIViC) PMID 34588615 · Aliagas et al., 2021 · Open in CIViC | civic |
| BARD1 ISOFORM EXPRESSION1 | |||||||
| Apitolisib + OlaparibCombination | Predictive | D | Supports Sensitivity Response | 3 | rejected | EID5998MPM cells transfected with BAP1Δ, an alternative splice isoform of BAP1 that misses part of the catalytic domain, showed reduced deubiquitinating activity compared with full-length BAP1. MPM cell line… (full text at CIViC) PMID 28389374 · Parrotta et al., 2017 · Open in CIViC | civic |
| ALK Fusion1 | |||||||
| Alectinib | Predictive | C | Supports Sensitivity Response | 4 | accepted | EID9228A 33 year old M non-smoker with no cancer family history and no known exposure to asbestos showed weakness, chest pain, and plural effusion (PE) accumulation. Mass in right lung was seen under enhance… (full text at CIViC) PMID 32600123 · Hu et al., 2020 · Open in CIViC | civic |
| ALK G1202R + ALK I1171N + ALK L1196M + ALK Fusion1 | |||||||
| Lorlatinib | Predictive | C | Supports Resistance | 3 | accepted | EID11114This case report describes a 33 year-old non-smoker with no known exposure to asbestos who was diagnosed with stage IIIB malignant pleural mesothelioma. Panel next generation sequencing (NGS) of 520 g… (full text at CIViC) PMID 32600123 · Hu et al., 2020 · Open in CIViC | civic |
| ALK I1171N + ALK L1196M + ALK Fusion2 | |||||||
| Alectinib | Predictive | C | Supports Resistance | 4 | accepted | EID11115A 33 year old male with no smoking history or known exposure to asbestos was diagnosed with malignant pleural mesothelioma (MPM). EML4::ALK was found using a panel of 520 genes in NGS, and the patient… (full text at CIViC) PMID 32600123 · Hu et al., 2020 · Open in CIViC | civic |
| Lorlatinib | Predictive | C | Supports Sensitivity Response | 3 | accepted | EID11113This case report describes a 33 year-old non-smoker with no known exposure to asbestos who was diagnosed with stage IIIB malignant pleural mesothelioma. Panel next generation sequencing (NGS) of 520 g… (full text at CIViC) PMID 32600123 · Hu et al., 2020 · Open in CIViC | civic |
| ERCC1 Expression1 | |||||||
| (prognostic) | Prognostic | B | Supports Poor Outcome | 4 | submitted | EID9234The paper evaluated tissue samples from 73 patients (male and female) for IHC staining of ERCC1 and RRM1. They found that dual expression was associated with later stage MPM and poorer overall surviva… (full text at CIViC) PMID 32842027 · Zito Marino et al., 2021 · Open in CIViC | civic |
| MDM2 EXPRESSION2 | |||||||
| (prognostic) | Prognostic | B | Supports Poor Outcome | 3 | accepted | EID82872 patients with malignant pleural mesothelioma were analyzed, MDM2 immunoexpression was assessed in 65 patients. MDM2 mRNA and protein expression correlated with poor OS and PFS for patients treated … (full text at CIViC) PMID 25668009 · Walter et al., 2015 · Open in CIViC | civic |
| Cisplatin + PemetrexedCombination | Predictive | B | Supports Resistance | 1 | accepted | EID82772 patients with malignant pleural mesothelioma were analyzed, MDM2 immunoexpression was assessed in 65 patients. MDM2 mRNA and protein expression correlated with poor OS and PFS for patients treated … (full text at CIViC) PMID 25668009 · Walter et al., 2015 · Open in CIViC | civic |
| NRAS Q61H1 | |||||||
| (diagnostic) | Diagnostic | D | Supports Positive | 3 | submitted | EID7332Mice that carried the Q61H variant had Malignant Pleural Mesothelioma and Lewis Lung Carincoma. The malignant cells where taken and each cell line was shown to readily promote lung colonization compar… (full text at CIViC) PMID 28341702 · Giannou et al., 2017 · Open in CIViC | civic |
Data updated 22 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.